Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

BACKGROUND: The current standard of care for newly diagnosed glioblastoma (GBM) is surgical resection, followed by radiation therapy (RT) with concurrent and adjuvant temozolomide chemotherapy (TMZ-CHT). The patients outcome is still poor. In this study we evaluated hypofractionated radiation therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarria, Pierina, Pessina, Federico, Tomatis, Stefano, Soffietti, Riccardo, Grimaldi, Marco, Lopci, Egesta, Chiti, Arturo, Leonetti, Antonella, Casarotti, Alessandra, Rossi, Marco, Cozzi, Luca, Ascolese, Anna Maria, Simonelli, Matteo, Marcheselli, Simona, Santoro, Armando, Clerici, Elena, Bello, Lorenzo, Scorsetti, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620204/
https://www.ncbi.nlm.nih.gov/pubmed/28978064
http://dx.doi.org/10.18632/oncotarget.18809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620204/
https://www.ncbi.nlm.nih.gov/pubmed/28978064
http://dx.doi.org/10.18632/oncotarget.18809

Ejemplares similares